NEW YORK, Sept. 30, 2024 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for October, November, and December 2024, as summarized in the charts below: ______________________________________________________________________________ | --- | --- | --- | |--------------|--------------------------------------------------------------------|----------------------------| | Ticker \nFOF | Fund Name \nCohen & Steers Closed-End Opportunity Fund, In ...

NEWTON, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease, announced today that management will participate in a fireside chat at the Bank of America CNS Therapeutics Virtual Conference on Monday, Oct. 7, 2024, at 8:00 a.m. ET. The live webcast may be accessed under the Investors tab on www.acumenpharm.com an ...

LONDON, Sept. 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, will hold investor calls this week to discuss its unaudited results for the six months ended 30 June 2024. The calls will be led by Corero's CEO, Carl Herberger, and newly appointed CFO, Chris Goulden, and will provide insight into the company's financial performance, strategic initiatives, and outlook for the remainder of the year. Corero's H1 2024 resul ...

NEW YORK, Sept. 12, 2024 /PRNewswire/ -- SUBSCRIBE, a leading operating system for alternative investments serving institutional investors, wealth management firms, and fund managers, announced today that leading real assets investment manager Cohen & Steers (NYSE: CNS) has joined the SUBSCRIBE platform to offer its private real estate strategies. The implementation of a centralized operating system will streamline investment and operational processes for clients in the private wealth channel while expandin ...

NEW YORK, Sept. 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.1 billion as of August 31, 2024, an increase of $3.5 billion from assets under management of $84.6 billion at July 31, 2024. The increase was due to market appreciation of $3.7 billion and net inflows of $8 million, partially offset by distributions of $152 million. Assets Under Management (unaudited) | --- | --- | --- | --- | --- | --- | |------------------------------|------- ...

MARLBOROUGH, Mass., Aug. 22, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced the signing of three new strategic partner agreements in Chile with NovaRed, Vista Group International Ltd (VGL), and GreyMatter. These partnerships mark a significant milestone in Corero's continued expansion and commitment to strengthening its presence in the Latin American market. NovaRed is a leading cybersecurity company ba ...

NEW YORK, Aug. 19, 2024 /PRNewswire/ -- Cohen & Steers, Inc.'s (NYSE: CNS) Board of Directors has appointed Lisa Dolly as a director of the company. Ms. Dolly has also been appointed as a member of the Board's Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Ms. Dolly is the former Chief Executive Officer of Pershing LLC, a subsidiary of The Bank of New York Mellon Corporation. Ms. Dolly's career spanned over 30 years at Pershing, including over two decades in seni ...

Plus' CNSide leptomeningeal metastases (LM) FORSEE trial met key primary and secondary endpoints CNSide more than doubled the diagnostic sensitivity vs. gold standard cerebral spinal fluid (CSF) cytology and influenced clinical management decisions in over 90% of LM cases AUSTIN, Texas, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for centra ...

Respect-LM dosing shows continued feasibility and safety of up to 44 mCi of intrathecal Rhenium (186Re) Obisbemeda High absorbed radiation doses, mean circulating tumor cell reductions, and median overall survival of 12 months continue to show clinical promise AUSTIN, Texas, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous sy ...

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on August 16, 2024. Cohen & Steers Global Realty Majors Portfolio Index (GRM) Added component (symbol) Removed component (symbol) Stockland Corporation Ltd. (SGP.AU) Mirvac Group (MGR.AU) KDX Realty Investment Corp. (8972.JP) Orix JREIT Inc. (8954.JP) Cohen & Steer ...